LDHA and osteoarthritis: Studies have also shown that treatment with the lactate dehydrogenase A (LDHA) inhibitor GSK2837808A results in a shift in the dampened ATP/AMP ratio back to baseline and increased hyaluronic acid secretion in activated osteoarthritis fibroblasts [154], and can restore effector T-cell function even in the presence of lactate [37].